illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. Amyris
Company logo

Amyris | Sustainability Performance

https://amyris.com
Linkedin

Amyris develops and produces sustainable ingredients for use in health, beauty, and industrial applications through biotechnology innovation.

2003

United States

1,001 - 5,000 employees

Biotechnology

$100M - 500M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#10825
Overall
#2419
in United States
#224
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Environmental
Digital emissions

View similiar companies

Company logo
Arcturus Therapeutics

United States, Hospital & Health Care, Biotechnology

Company logo
NeueHealth

United States, Hospital & Health Care, Hospital & Health Care

Company logo
Envista

United States, Hospital & Health Care, Medical Device

Digital Emissions

CO2e per visit (g)

Industry benchmark

B/M 0.26 g
0 g
Green HostingYes
Download Digital Emissions AnalysisPowered by illuminem and Dedalo AI

Controversy level

Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • Amyris filed for Chapter 11 bankruptcy in August 2023 with USD 900 million debt amid sustained losses and synthetic biology commercialization challenges, affecting consumer beauty brand customers and bondholders.
Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

 Available

Sustainability employees

Total sustainability employees

4-6

    Available in
    Scale package

    Access
  • Email
  • Email